figshare
Browse
Figure_8.tif (3.79 MB)

Models for how CADs May Block EBOV Entry.

Download (0 kB)
figure
posted on 2013-02-18, 02:19 authored by Charles J. Shoemaker, Kathryn L. Schornberg, Sue E. Delos, Corinne Scully, Hassan Pajouhesh, Gene G. Olinger, Lisa M. Johansen, Judith M. White

(A) In the first model, the CADs (yellow star) interact directly with NPC1, but at a site distinct from the C loop of NPC1 (which binds GP19 kDa). Binding to NPC1 inhibits a second function of NPC1 (i.e. in addition to its role in binding GP19 kDa) that is critical for EBOV entry. (B) In the second model, the CADs intercalate into the LE/Lys membrane, indirectly inhibiting a second function of NPC1 that promotes EBOV entry. (C) In a final model, the CADs disrupt a target distinct from NPC1 that is critical for EBOV fusion with LE/Lys) and is regulated by NPC1. The target may be another LE/Lys protein (e.g. ASM) or a lipid of the LE/Lys membrane system. (See text for details.) Alternatively, the CADs may interfere with NPC1-dependent membrane trafficking [47], [50] such that the virus is never found in an NPC1-containing compartment. In all of the models, the yellow star denotes a CAD and red in each middle image denotes the target molecule.

History

Usage metrics

    PLOS ONE

    Keywords

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC